change noted, page-8

here tis,

"Finally, to the world's most exciting biotechnology company, PharmaNet. PharmaNet, which only a couple of months ago announced that it had discovered a cure for pain -- and later specified that its 'Tripeptofen compound' which cures pain had been identified in one of its existing therapeutic products -- was the top-traded stock on the market yesterday. With 130 million shares traded, the stock has now shot from 4c to 7.3c.

Yesterday's news was that scientists from Curtin University would be working to ensure that 'the program was compatible with the highest European and US regulatory requirements'.

Unfortunately, one of PharmaNet's directors, Phil Garrett (who has a vivid track record in Canadian emerging companies), had sold some of his stock a couple of days before the big news." Michael West, the Australian